Alkylresorcinol metabolites

ID93
NameAlkylresorcinol metabolites
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupAlkylresorcinols
Exposure sourceDiet
Use
CAS number
PubChem ID
ChEBI ID
FooDB ID
HMDB ID

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
6480AllWomen living in the Helsinki areaFinlandFIPlasma, fastingHPLC after enzymatic hydrolysisAlkylresorcinol metabolites3,5-Dihydroxybenzoic acid
3-(3,5-Dihydroxyphenyl)-1-propanoic acid
56185.0135.0nmol/L185.0 nmol/LCrudeAubertin-Leheudre 2010
6930AllWomen participant in the hormone stability studyUnited StatesUSNHS II (Nurses' Health Study II)1 yearUrine, first morning spotGC-MS after enzymatic hydrolysisAlkylresorcinol metabolites3,5-Dihydroxybenzoic acid
3-(3,5-Dihydroxyphenyl)-1-propanoic acid
10412.010.313.9umol/L12000.0 nmol/LRegressionCreatinineLandberg 2012
6940AllWomen participant in the hormone stability studyUnited StatesUSNHS II (Nurses' Health Study II)2.8 yearsUrine, first morning spotGC-MS after enzymatic hydrolysisAlkylresorcinol metabolites3,5-Dihydroxybenzoic acid
3-(3,5-Dihydroxyphenyl)-1-propanoic acid
10413.411.615.5umol/L13400.0 nmol/LRegressionCreatinineLandberg 2012

Intake values

No data available

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
3697AllWomen participant in the hormone stability studyUnited StatesUSNHS II (Nurses' Health Study II)1 year; 2.8 yearsUrine, first morning spotGC-MS after enzymatic hydrolysisAlkylresorcinol metabolites3,5-Dihydroxybenzoic acid
3-(3,5-Dihydroxyphenyl)-1-propanoic acid
umol/L950.210.080.4554.128.4Landberg 2012